Summary
Novo Nordisk reported a cyberattack on June 11, 2026, involving the unauthorized exfiltration of pseudonymized clinical trial patient data from its internal IT systems. The company isolated affected infrastructure and launched a forensic investigation. The core pharmaceutical operations are not affected.
Read the full article on BeyondMachines
This article was originally published on BeyondMachines
Top comments (0)